BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 35917013)

  • 21. Combination of extramural venous invasion and lateral lymph node size detected with magnetic resonance imaging is a reliable biomarker for lateral lymph node metastasis in patients with rectal cancer.
    Abe T; Yasui M; Imamura H; Matsuda C; Nishimura J; Haraguchi N; Nakai N; Wada H; Takahashi H; Omori T; Miyata H; Ohue M
    World J Surg Oncol; 2022 Jan; 20(1):5. PubMed ID: 34986842
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Value and related factors of preoperative diagnosis of extramural vascular invasion of rectal cancer by 3.0T magnetic resonance imaging].
    Wang YJ; Chen Y; Lyu XT; Ma AL; He YP; Gao ZL
    Zhonghua Zhong Liu Za Zhi; 2019 Aug; 41(8):610-614. PubMed ID: 31434453
    [No Abstract]   [Full Text] [Related]  

  • 23. Prognostic significance of magnetic resonance imaging-detected extramural vascular invasion in rectal cancer.
    Smith NJ; Barbachano Y; Norman AR; Swift RI; Abulafi AM; Brown G
    Br J Surg; 2008 Feb; 95(2):229-36. PubMed ID: 17932879
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systematic review of prognostic importance of extramural venous invasion in rectal cancer.
    Chand M; Siddiqui MR; Swift I; Brown G
    World J Gastroenterol; 2016 Jan; 22(4):1721-6. PubMed ID: 26819536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MRI-detected extramural vascular invasion is an independent prognostic factor for synchronous metastasis in patients with rectal cancer.
    Sohn B; Lim JS; Kim H; Myoung S; Choi J; Kim NK; Kim MJ
    Eur Radiol; 2015 May; 25(5):1347-55. PubMed ID: 25500963
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extramural venous invasion in rectal cancer: overview of imaging, histopathology, and clinical implications.
    Ale Ali H; Kirsch R; Razaz S; Jhaveri A; Thipphavong S; Kennedy ED; Jhaveri KS
    Abdom Radiol (NY); 2019 Jan; 44(1):1-10. PubMed ID: 29967984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination of three-gene immunohistochemical panel and magnetic resonance imaging-detected extramural vascular invasion to assess prognosis in non-advanced rectal cancer patients.
    Li XF; Jiang Z; Gao Y; Li CX; Shen BZ
    World J Gastroenterol; 2016 Oct; 22(38):8576-8583. PubMed ID: 27784970
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MRI of Extramural Venous Invasion in Locally Advanced Rectal Cancer: Relationship to Tumor Recurrence and Overall Survival.
    Zhang XY; Wang S; Li XT; Wang YP; Shi YJ; Wang L; Wu AW; Sun YS
    Radiology; 2018 Dec; 289(3):677-685. PubMed ID: 30152742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The prognostic significance of extramural venous invasion detected by multiple-row detector computed tomography in stage III gastric cancer.
    Cheng J; Wu J; Ye Y; Zhang C; Zhang Y; Wang Y
    Abdom Radiol (NY); 2016 Jul; 41(7):1219-26. PubMed ID: 27315092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extramural venous invasion (EMVI) revisited: a detailed analysis of various characteristics of EMVI and their role as a predictive imaging biomarker in the neoadjuvant treatment response in rectal cancer.
    Altinmakas E; Dogan H; Taskin OC; Ozoran E; Bugra D; Adsay V; Balik E; Gurses B
    Abdom Radiol (NY); 2022 Jun; 47(6):1975-1987. PubMed ID: 35332398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of tissue sampling on detection of venous invasion in colorectal cancer: a prospective analysis.
    Duan K; Chow B; Tsui W; Elliot C; Sari A; Shivji S; Kirsch R; Conner JR
    Histopathology; 2023 Dec; 83(6):891-902. PubMed ID: 37580911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exploration of Malignant Characteristics in Neoadjuvant Chemotherapy-Resistant Rectal Cancer, Focusing on Extramural Lesions.
    Kubota S; Miura T; Wakiya T; Yoshizawa T; Goto S; Morohashi H; Sakamoto Y; Tatara Y; Kijima H; Hakamada K
    Ann Surg Oncol; 2023 Nov; 30(12):7612-7623. PubMed ID: 37548833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of intramural and extramural vascular invasion on stage II-III colon cancer outcomes.
    Leijssen LGJ; Dinaux AM; Amri R; Taylor MS; Deshpande V; Bordeianou LG; Kunitake H; Berger DL
    J Surg Oncol; 2019 May; 119(6):749-757. PubMed ID: 30644557
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical value of MRI-detected extramural venous invasion in rectal cancer.
    Tripathi P; Rao SX; Zeng MS
    J Dig Dis; 2017 Jan; 18(1):2-12. PubMed ID: 28009094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic significance of computed tomography-detected extramural vascular invasion in colon cancer.
    Yao X; Yang SX; Song XH; Cui YC; Ye YJ; Wang Y
    World J Gastroenterol; 2016 Aug; 22(31):7157-65. PubMed ID: 27610025
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The prognostic significance of MRI-detected extramural venous invasion, mesorectal extension, and lymph node status in clinical T3 mid-low rectal cancer.
    Gu C; Yang X; Zhang X; Zheng E; Deng X; Hu T; Wu Q; Bi L; Wu B; Su M; Wang Z
    Sci Rep; 2019 Aug; 9(1):12523. PubMed ID: 31467313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adjuvant therapy decisions based on magnetic resonance imaging of extramural venous invasion and other prognostic factors in colorectal cancer.
    Chand M; Swift RI; Chau I; Heald RJ; Tekkis PP; Brown G
    Ann R Coll Surg Engl; 2014 Oct; 96(7):543-6. PubMed ID: 25245736
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Magnetic resonance and extramural vascular invasion in patients with rectal cancer and liver metastases].
    Seehaus A; Vaccaro C; Quadrelli M; Calvo M; Rossi G; Savluk L; Pablo Santino J; Ojea Quintana G; García Mónaco R
    Acta Gastroenterol Latinoam; 2015 Mar; 45(1):31-6. PubMed ID: 26076511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of Extramural Venous Invasion by Diffusion-Weighted Magnetic Resonance Imaging and Computed Tomography in Rectal Adenocarcinoma.
    Gursoy Coruh A; Peker E; Elhan A; Erden I; Erden A
    Can Assoc Radiol J; 2019 Nov; 70(4):457-465. PubMed ID: 31582328
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mismatch repair-deficient colorectal cancer: a model of immunogenic and immune cell-rich tumor despite nonsignificant programmed cell death ligand-1 expression in tumor cells.
    Le Flahec G; Badic B; Guibourg B; Doucet L; Bail JP; Marcorelles P; Schick U; Uguen A
    Hum Pathol; 2018 Feb; 72():135-143. PubMed ID: 29208565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.